BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16635329)

  • 1. [Study on mRNA expression of the human novel gene NM23-H1B in ovarian tumor].
    Li W; Liu Y; Jin ZJ; Feng YJ; Huang LM; Chen J
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jan; 41(1):48-51. PubMed ID: 16635329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression.
    Mandai M; Konishi I; Koshiyama M; Mori T; Arao S; Tashiro H; Okamura H; Nomura H; Hiai H; Fukumoto M
    Cancer Res; 1994 Apr; 54(7):1825-30. PubMed ID: 7907945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppressive role of the metastasis-related nm23-H1 gene in human ovarian carcinomas: association of high messenger RNA expression with lack of lymph node metastasis.
    Viel A; Dall'Agnese L; Canzonieri V; Sopracordevole F; Capozzi E; Carbone A; Visentin MC; Boiocchi M
    Cancer Res; 1995 Jun; 55(12):2645-50. PubMed ID: 7780979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between Nm23-H1 gene expression and metastasis of ovarian carcinoma.
    Gao QL; Ma D; Meng L; Wang SX; Wang CY; Lu YP; Zhang AL; Li J
    Ai Zheng; 2004 Jun; 23(6):650-4. PubMed ID: 15191664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and characterization of a novel human NM23-H1B gene, a different transcript of NM23-H1.
    Ni X; Gu S; Dai J; Cheng H; Guo L; Li L; Ji C; Xie Y; Ying K; Mao Y
    J Hum Genet; 2003; 48(2):96-100. PubMed ID: 12601555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The lysophosphatidic acid (LPA) receptors their expression and significance in epithelial ovarian neoplasms.
    Wang P; Wu X; Chen W; Liu J; Wang X
    Gynecol Oncol; 2007 Mar; 104(3):714-20. PubMed ID: 17204312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of MDR-1, nm23-H1 and H Sema E gene expression with histopathological findings and clinical outcome in ovarian and breast cancer patients.
    Galani E; Sgouros J; Petropoulou C; Janinis J; Aravantinos G; Dionysiou-Asteriou D; Skarlos D; Gonos E
    Anticancer Res; 2002; 22(4):2275-80. PubMed ID: 12174914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of E-cadherin and nm23 is associated with the clinicopathological factors of human non-small cell lung cancer in China.
    Chen XF; Zhang HT; Qi QY; Sun MM; Tao LY
    Lung Cancer; 2005 Apr; 48(1):69-76. PubMed ID: 15777972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Northern blot analysis of nm23 gene expression in human lung cancer].
    Liu L; Qin Y; Zhou Q
    Zhonghua Zhong Liu Za Zhi; 1998 Sep; 20(5):342-4. PubMed ID: 10921026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular mechanism of reversing metastatic phenotype in human high-metastatic large cell lung cancer cell line L9981 by nm23-H1].
    Che GW; Zhou QH; Zhu W; Wang YP; Qin Y; Liu LX; Chen XH; Sun YL; Sun ZF
    Ai Zheng; 2005 Mar; 24(3):278-84. PubMed ID: 15757527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. nm23-H1 expression defines a high-risk subpopulation of patients with early-stage epithelial ovarian carcinoma.
    Schneider J; Pollán M; Jiménez E; Marenbach K; Martínez N; Volm M; Marx D; Meden H
    Br J Cancer; 2000 May; 82(10):1662-70. PubMed ID: 10817501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Human pituitary tumor transforming gene 1 expression in ovarian carcinoma and its clinical significance].
    Cheng YX; Feng J; Zhang XY; Fu TY; Yao Y
    Ai Zheng; 2004 Sep; 23(9):1026-30. PubMed ID: 15363195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Micrometastasis and expression of nm23 messenger RNA of lymph nodes from lung cancer and the postoperative clinical outcome.
    Ayabe T; Tomita M; Matsuzaki Y; Ninomiya H; Hara M; Shimizu T; Edagawa M; Onitsuka T; Hamada M
    Ann Thorac Cardiovasc Surg; 2004 Jun; 10(3):152-9. PubMed ID: 15312010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of antimetastatic gene nm23-H1 in epithelial ovarian cancer.
    Qian M; Feng Y; Xu L; Zheng S; Zhou X
    Chin Med J (Engl); 1997 Feb; 110(2):142-4. PubMed ID: 9594287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. nm23 expression in advanced and borderline ovarian carcinoma.
    Schneider J; Romero H; Ruiz R; Centeno MM; Rodriguez-Escudero FJ
    Anticancer Res; 1996; 16(3A):1197-202. PubMed ID: 8702236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of nm23 in breast cancer: correlation with distant metastasis and prognosis].
    Liu H; Mao H; Fu X
    Zhonghua Zhong Liu Za Zhi; 2001 May; 23(3):224-7. PubMed ID: 11783092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A study on C-erbB2, nm23 and p53 expressions in epithelial ovarian cancer and their clinical significance].
    Liu L; Yang K
    Zhonghua Fu Chan Ke Za Zhi; 1999 Feb; 34(2):101-4. PubMed ID: 11263193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of DNA methyltransferase 1, 3A and 3B mRNA in the epithelial ovarian carcinoma].
    Chen CL; Yan X; Gao YN; Liao QP
    Zhonghua Fu Chan Ke Za Zhi; 2005 Nov; 40(11):770-4. PubMed ID: 16324253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of nm23 gene expression in gastric cancer.
    Mönig SP; Nolden B; Lübke T; Pohl A; Grass G; Schneider PM; Dienes HP; Hölscher AH; Baldus SE
    Anticancer Res; 2007; 27(4C):3029-33. PubMed ID: 17695492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression and clinical significance of endostatin and vascular endothelial growth factor in ovarian carcinoma].
    Shi HR; Song WJ; Chen ZM; Wu QH
    Ai Zheng; 2005 Sep; 24(9):1127-31. PubMed ID: 16159439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.